Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.
E
Fourth Extension - Granted
Show more
Class 5: Pharmaceutical and biological preparations based on genome editing and engineering for use in human therapeutics, namely, for the treatment of cancer and/or genetic diseases
Class 42: Medical and scientific research information in the field of genome editing and engineering, gene modulation, gene repair, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; Pharmaceutical research and development; Pharmaceutical research services; Providing medical research and scientific research information in the fields of genome editing and engineering, gene modulation, gene repair, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy
Class 5 – Pharmaceuticals & supplementsClass 42 – Technology & SaaS
Status timeline
- 12 May 2023Application filedNew Application Entered
- 4 Sep 2023Assigned to an examining attorneyAssigned To Examiner
- 5 Sep 2023Office action issuedNon-Final Action Written
- 4 Dec 2023Response to office action filedTeas Response To Office Action Received
- 5 Dec 2023Approved for publicationApproved For Pub - Principal Register
- 9 Jan 2024Published for oppositionPublished For Opposition
- 5 Mar 2024Notice of allowance issued — statement of use requiredNoa Mailed - Sou Required From Applicant
- 10 Dec 2024Statement-of-use extension 1 grantedSou Extension 1 Granted
- 7 Feb 2025Statement-of-use extension 2 grantedSou Extension 2 Granted
- 5 Aug 2025Statement-of-use extension 3 grantedSou Extension 3 Granted
All 40 events
| 2026-02-20 | Sou Teas Extension Received |
| 2026-02-20 | Sou Extension 4 Filed |
| 2026-02-20 | Sou Extension 4 Granted |
| 2026-02-20 | Notice Of Approval Of Extension Request E-Mailed |
| 2025-08-06 | Notice Of Approval Of Extension Request E-Mailed |
| 2025-08-05 | Sou Teas Extension Received |
| 2025-08-05 | Sou Extension 3 Filed |
| 2025-08-05 | Sou Extension 3 Granted |
| 2025-02-10 | Notice Of Approval Of Extension Request E-Mailed |
| 2025-02-07 | Sou Teas Extension Received |
| 2025-02-07 | Sou Extension 2 Filed |
| 2025-02-07 | Sou Extension 2 Granted |
| 2024-12-10 | Sou Extension 1 Granted |
| 2024-12-10 | Notice Of Approval Of Extension Request E-Mailed |
| 2024-12-09 | Case Assigned To Intent To Use Paralegal |
| 2024-10-11 | Teas Change Of Owner Address Received |
| 2024-10-11 | Applicant/Correspondence Changes (Non-Responsive) Entered |
| 2024-10-11 | Teas Revoke/App/Change Addr Of Atty/Dom Rep Received |
| 2024-10-11 | Attorney/Dom.rep.revoked And/Or Appointed |
| 2024-10-11 | Teas Change Of Correspondence Received |
| 2024-09-17 | Teas Petition To Revive Received |
| 2024-09-17 | Petition To Revive-Granted |
| 2024-09-17 | Notice Of Revival - E-Mailed |
| 2024-09-17 | Sou Extension Received With Teas Petition |
| 2024-09-05 | Sou Extension 1 Filed |
| 2024-03-05 | Noa Mailed - Sou Required From Applicant |
| 2024-01-09 | Published For Opposition |
| 2024-01-09 | Official Gazette Publication Confirmation E-Mailed |
| 2023-12-20 | Notification Of Notice Of Publication E-Mailed |
| 2023-12-05 | Teas/Email Correspondence Entered |
| 2023-12-05 | Approved For Pub - Principal Register |
| 2023-12-04 | Teas Response To Office Action Received |
| 2023-12-04 | Correspondence Received In Law Office |
| 2023-09-05 | Non-Final Action Written |
| 2023-09-05 | Non-Final Action E-Mailed |
| 2023-09-05 | Notification Of Non-Final Action E-Mailed |
| 2023-09-04 | Assigned To Examiner |
| 2023-06-09 | Notice Of Design Search Code E-Mailed |
| 2023-06-08 | New Application Office Supplied Data Entered |
| 2023-05-12 | New Application Entered |
Goods & services by class
Class 5 Pharmaceuticals & supplements
Pharmaceutical and biological preparations based on genome editing and engineering for use in human therapeutics, namely, for the treatment of cancer and/or genetic diseases
Class 42 Technology & SaaS
Medical and scientific research information in the field of genome editing and engineering, gene modulation, gene repair, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; Pharmaceutical research and development; Pharmaceutical research services; Providing medical research and scientific research information in the fields of genome editing and engineering, gene modulation, gene repair, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy
Owner details
See the official record for contact details. View official record →
Source & freshness
Source: the official United States trademark register. This record was last updated on 21 Feb 2026; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.